ArticleNPJ biofilms and microbiomes2026
Goat gut microbiome as a reservoir for microorganism-encoded short peptides: regulation by host development age and nematode challenge.
Article in NPJ biofilms and microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Short peptides are a promising class of antimicrobial agents with efficacy against multidrug-resistant pathogens. While host-derived defense peptides from animals and plants have been widely characterized, the landscape of microbial-encoded short peptides, particularly those with antimicrobial activity that can mitigate antibiotic resistance, remains underexplored. In this study, we identified 1147 novel microorganism-encoded short peptides (MSPs) from the goat gut microbiome, most of which lack homology to existing database entries. The microbial communities producing these MSPs were altered by the developmental stage of the goat, whereas the overall composition and diversity of these populations remained unchanged during nematode infection, despite significant correlations between certain MSPs and type 2 immunity. Notably, two MSPs demonstrated potent antimicrobial activity with lower cytotoxicity, exhibiting remarkable efficacy against methicillin-resistant Staphylococcus aureus and Streptococcus agalactiae. Collectively, our findings establish the goat gastrointestinal tract microbiome as a distinctive and promising reservoir for the discovery of antimicrobial and immunoregulatory peptides.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.